Literature DB >> 25916762

Problems with the PTH assays.

Etienne Cavalier1, Pierre Delanaye2, Laurent Nyssen3, Jean-Claude Souberbielle4.   

Abstract

Even if the first assay for parathyroid hormone (PTH) was published in the early 1960s, its determination remains a challenge even today. Indeed, in the circulation, PTH is present in its active form (PTH 1-84), but many PTH fragments can also be present. These fragments accumulate when renal function declines and are recognized, at different extents, by the 2nd generation ("intact") PTH assays that are widely used in the clinical laboratories. Some assays, called "3rd generation PTH" do not recognize these fragments, but are not available everywhere. Hence, different problems are also linked with PTH determination. Among them, one can cite the lack of a reference method, the lack of standardization of the assays and, sometimes, the lack of consistent reference range. We can also point out stability problems and a large intra-individual variation. A workgroup is working on these problems under the auspices of the IFCC and we hope that some of these problems will be resolved in the next years. In this article, we will discuss all the possible issues of PTH determination.
Copyright © 2015. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Dosage de l’hormone parathyroïdienne; Fragments de PTH; PTH assays; PTH fragments; Parathyroid hormone measurement; Trousses de PTH

Mesh:

Substances:

Year:  2015        PMID: 25916762     DOI: 10.1016/j.ando.2015.03.018

Source DB:  PubMed          Journal:  Ann Endocrinol (Paris)        ISSN: 0003-4266            Impact factor:   2.478


  3 in total

1.  The most reliable time point for intact parathyroid hormone measurement to predict hypoparathyroidism after total thyroidectomy with central neck dissection to treat papillary thyroid carcinoma: a prospective cohort study.

Authors:  Jae Won Chang; Ki Wan Park; Seung-Nam Jung; Lihua Liu; Sung Min Kim; Bon Seok Koo
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-10-16       Impact factor: 2.503

Review 2.  Hope for CKD-MBD Patients: New Diagnostic Approaches for Better Treatment of CKD-MBD.

Authors:  Berthold Hocher; Andreas Pasch
Journal:  Kidney Dis (Basel)       Date:  2017-06-16

3.  Establish pre-clinical diagnostic efficacy for parathyroid hormone as a point-of-surgery-testing-device (POST).

Authors:  Ambalika S Tanak; Sriram Muthukumar; Ibrahim A Hashim; Shalini Prasad
Journal:  Sci Rep       Date:  2020-11-02       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.